In what’s been described as a ‘paradigm shifter’ for psychiatry, clinical trials are exploring the therapeutic use for illegal substances
It was out of desperation that Michael Raymond found himself sitting in a remote retreat in the Peruvian Andes, sipping a cup of bitter tea.
Raymond had reached breaking point. His 16-year career as an electrical engineer in high–security situations for the Australian air force had seen him deal with near-death experiences, crashes, casualties and “the aftermath of human remains”.